We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Infrainguinal Bypass Surgery Shows High Perioperative Morbidity

By HospiMedica staff writers
Posted on 17 Jun 2008
A new study exhorts that stringent indications for infrainguinal bypass surgeries (BPG) should be maintained, and when clinically and anatomically feasible, endovascular procedures should be considered as the initial therapy for infrainguinal arterial reconstruction.

Researchers at Massachusetts General Hospital (Boston, USA) collected data from the U.S. More...
National Surgical Quality Improvement Program, which provided statistics for 2,404 BPGs (infrapopliteal distal anastomosis 42%, prosthetic 29%), derived from multiple private sector hospitals around the United States. Patients ranged from 66 to 69 years and 66% were male; 48% had diabetes and the indication for surgery was limb salvage in 48%.

The researchers found that overall mortality was 2.7% and correlated with patient age, weight, significant dyspnea, dialysis, history of transient ischemic attack (TIA), and bleeding disorders. Major complications of BPG occurred in 18.7% of the patients including 7.4 % graft thromboses and 11.7% wound infections. Major systemic complications occurred in 5.9% and correlated to age, history of myocardial infarction (MI), dialysis, impaired sensorium, and general anesthesia. Major operative site-related complications occurred in 15.1% and correlated to a history of chronic obstructive pulmonary disease (COPD), limb salvage, impaired sensorium, non-independent preoperative functional status, and operative time. The study was presented at the Society for Vascular Surgery (SVS) Vascular annual meeting, held during June 2008 in San Diego (CA, USA).

"Our study shows that infrainguinal BPG carries with it a non-trivial complication rate which we need to fully appreciate,” said lead author Glenn LaMuraglia, M.D., an associate professor of surgery. "The results of this study, which delineates the systemic and the local surgical complications, should assist us in taking better care of our patients with lower extremity ischemia.”

According to Dr. LaMuraglia, the decision to use BPG or endovascular procedures to treat lower extremity vascular disease is partly dependent on periprocedural outcomes. Endovascular procedures, such as percutaneous transluminal angioplasty should be considered as the initial therapy for infrainguinal arterial reconstruction because they have been previously reported to carry lower complication rates.


Related Links:
Massachusetts General Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.